Michalek, Jaroslav
Hezova, Renata
Turanek-Knötigova, Pavlina
Gabkova, Jana
Strioga, Marius
Lubitz, Werner
Kudela, Pavol
Article History
Received: 19 January 2016
Accepted: 14 November 2016
First Online: 18 November 2016
Conflict of interest
: Jaroslav Michalek is a founder and CEO of Cellthera, s.r.o., Brno, Czech Republic, and inventor of Patent EP2591798B1 Vaccine for use in tumor immunotherapy. Werner Lubitz is a founder and CEO of BIRD-C GmbH, Vienna, Austria, which has licensed the rights to the Bacterial Ghosts Technology, and inventor and proprietor of Patent EP2591798B1 Vaccine for use in tumor immunotherapy. Pavol Kudela is an employee of BIRD-C GmbH, Vienna, Austria, and inventor of Patent EP2591798B1 Vaccine for use in tumor immunotherapy. All other authors declare that they have no conflict of interest.
Free to read: This content has been made available to all.